HotCopper.com on MSN5h
Another win for Clarity at FDA as imaging agent fast-tracked for complex prostate cancer
For those unlucky enough to have received a testicular castration to treat prostate cancer, only for it to come back, Clarity ...
UroToday15h
ASCO GU 2025: PREP - A Prospective Provincial Registry of PSMA PET CT for Recurrent Prostate Cancer: Results for 4,135 Men
GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Glenn Bauman discussing a prospective provincial registry of PSMA PET/CT for recurrent prostate cancer. While most ...
Black Hills Pioneer17h
Prostate Cancer Screening Hits the Streets With the 'Man Van'
TUESDAY, Feb. 18, 2025 (HealthDay News) -- A mobile "Man Van" screening program detected dozens of prostate cancer cases in ...
The American Journal of Managed Care4d
Receiving NADT for 6 Months Doesn’t Impact Outcomes in Intermediate-Risk Prostate Cancer After EBRT
Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...
Johns Hopkins Medicine6d
Kidney Scan
This means that a tiny amount of radioactive matter is used during the scan. The radioactive matter (radioactive tracer) is absorbed by normal kidney tissue. The radioactive tracer sends out gamma ...
Vietnam Investment Reviev6d
Illuccix Approved in the United Kingdom
Telix Pharmaceuticals Limited today announces that the United Kingdom Medicines and Healthcare Products Regulatory Agency has ...